Lubrizol Life Sciences

Activities: Manufacturing Ingredients

Trending Articles

  1. Enhancing solubility with novel excipients With the growing prevalence of complex drug molecules, formulation is becoming ever more challenging. Novel excipients can unlock their potential, says Meera Raghuram, Director...
  2. SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
  3. Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research...
  4. Buckland Group launches Quvara Medical after acquiring Becton Dickinson’s Swindon site to boost UK-EU medical manufacturing The acquisition establishes Quvara Medical as a new UK- and EU-based CMO offering GMP- and ISO-certified, high-volume manufacturing services to pharma and medtech clients
  5. SeaBeLife partners with Unither Pharmaceuticals for ophthalmic drug production The new partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate SBL03 to treat degenerative disorders of the...

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Ingredients

Lubrizol to showcase game-changing excipients and nutraceutical ingredients at CPHI Frankfurt

Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits
You need to be a subscriber to read this article.
Click here to find out more.
Dosage Forms

Dosage forms: solving the solubility challenge

The increasing number of poorly soluble APIs is driving innovation in the excipient sector as manufacturers look to enhance drug solubility and bioavailability, says Matt Finkelhor, Commercial Manager, Global Novel Polymers at Lubrizol
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Increasing efficacy in oral solid dose drug delivery

Using excipients that are well-suited for extended-release profiles in oral solid dosage forms can help to enhance a drug’s therapeutic effect and improve patient compliance
Ingredients

Lubrizol's polymer excipient Apisolex featured in Phase I candidate

The solubility-enhancing excipient is featured in a parenteral formulation that's currently undergoing global Phase I clinical trials
Ingredients

Lubrizol’s Apisolex Polymer wins Finished Formulation Award at CPhI Barcelona

The solubility-enhancing excipient for injectable drug formulations has won the prestigious CPhI Barcelona award
Regulatory

Lubrizol licenses novel excipient polymer technology to Welton Pharma

Introduced to the market last year, the patented Apisolex excipient is a polyamino-acid polymer designed for parenteral applications
Media

Manufacturing Chemist roundtable: Pharmaceutical trends to keep an eye on

From cannabis to containment and from regulatory affairs to Russia, 2019 presented the pharmaceutical industry with a number of hurdles and opportunities. A panel of industry experts examine how the slings and arrows of the past twelve months might affect the next ten years
Subscribe now